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Abstract 
We present a novel analytical platform for peptides quantitative assays in biological matrices based on 
microscale liquid chromatography fractionation and matrix-assisted laser desorption/ionization mass 
spectrometric detection using the selected reaction monitoring (SRM) mode. The MALDI source was 
equipped with a high frequency Nd:YAG laser (1000 Hz) and mounted on a triple quadrupole / linear 
ion trap mass spectrometer (MALDI-QqQLIT). Compared to conventional LC-ESI-SRM/MS, the 
separated analytes are “time-frozen” onto the MALDI plate in fractions and navigation through the LC 
chromatogram makes possible to perform SRM experiments as well as enhanced product ion spectra 
acquisition for confirmatory analyses without time constraints. The LC spots were analyzed using 
different rastering speeds ranging from 0.25 to 4 mm/sec with the shortest analysis time of 425 ms/spot. 
Since the LC runs can be multiplexed and do not need a comprehensive investigation, the present 
platform offers a valuable alternative to LC-ESI-SRM/MS for high throughput proteomic analyses. In 
addition, the derivatization of the N-terminal α-amino group by sulfonation was found to be key for the 
fragmentation of singly charged peptides under low collision energy regime. Under such conditions, y-
ion series were observed in the MS/MS spectra, and thus the design of SRM experiments was greatly 
simplified. The quantitative performance of the platform was compared to that of LC-ESI-SRM/MS by 
spiking yeast tryptic peptides in human plasma digests. Both platforms exhibited similar sensitivities, 
accuracy (within +/-20%) and precision (under 20%) in the relative quantification mode. As a proof of 
principle, the relative and absolute quantification of proteins associated with glycolysis, glyoxylate and 
tricarboxylic acid (TCA) cycles over a growth time course of Saccharomyces cerevisiae on glucose 
media, was successfully performed using isotopic dilution. 
 
Keywords:   Peptides, MALDI, quantification, SRM, yeast, chemically assisted fragmentation.
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Introduction 
The targeted mass spectrometry (MS) approach using a triple quadrupole operating in selected 
reaction monitoring (SRM) mode for the detection and quantification of peptides (as surrogates of their 
proteins) has gained in importance during the last decade. Experiments based on selected reaction 
monitoring, by contrast to the unsupervised shotgun approach requires the preselection of peptides 
representing the proteins of interest. Such peptides have to fulfill some particular criteria, including 
uniqueness of the amino acids sequences, MS-observable as tryptic products, and exhibiting collision-
induced fragment ions) prior to perform the LC-SRM/MS analysis 
1
. The SRM quantification, well 
established for small molecules analyses, has been recently applied for the absolute quantification of 
biopharmaceuticals and biomarkers 
2-4
 as well as for monitoring large sets of protein 
5-10
. The high 
selectivity of the SRM acquisition reduces significantly the need of sample fractionation and 
considerably simplifies post-acquisition data processing. Picotti et al. have demonstrated that a 30 
minutes LC gradient is sufficient for the monitoring of the glycolysis, tricarboxylic acid (TCA) and 
glyoxylate cycles proteins network of S. cerevisiae with sensitivity down to 50 proteins/cell and 
additional detection of previously undetected proteins 
11
. 
Nevertheless, LC-MS using electrospray ionization has limited analytical throughput and acquisition 
flexibility due to the intrinsic hyphenation between the chromatography and the mass spectrometer. On 
the contrary, matrix-assisted laser desorption ionization (MALDI) allows high throughput capabilities 
because the LC separation step is decoupled from the MS measurements. This promotes multiplexing 
the LC separation by fractionating simultaneously 2-4 samples onto the same MALDI plate, and a 
subsequent in-depth MS analysis. Currently most LC-MALDI assays are run on TOF/TOF 
instrumentation using high energy collision induced dissociation (CID) 
12
. MALDI ionization produces 
almost exclusively singly charged protonated peptides that do not usually provide reliable MS/MS 
spectra under low energy CID. Therefore, high energy CID is generally required to fragment singly 
charged peptides and the resulting MS/MS spectra can be complex exhibiting a, b, c, x, y, z series, 
internal and side-chain cleavage fragments d, v, w 
13
, which may affect the overall sensitivity of the 
assay. A chemically assisted fragmentation step is frequently applied to support TOF/TOF fragmentation 
of peptides and simplify the spectra interpretation with an enhancement of the signal to noise ratio 
14-16
. 
The chemically assisted fragmentation 
16-19
 consists in derivatizing the tryptic peptides using sulfonation 
reagents such as 4-sulfophenylisothiocyanate (SPITC). It is postulated that the strong negative charge, 
i.e. given by the sulfonate moiety localized at the N-terminus of the peptides, forces them to carry two 
protons in order to be ionized in positive mode 
17
. The sulfonated peptides remain singly charged but 
fragment readily due to the presence of two protons.  
The combination of a triple quadrupole with a MALDI source is a recent setup 
20-22
, which has been 
applied mainly in quantitative analysis of pharmaceuticals 
23, 24
, and MALDI-MS imaging of low 
molecular weight compounds 
25, 26
. This particular configuration encompasses a high frequency laser (up 
to 1000 Hz) in order to produce a quasi-continuous ions beam that is mandatory for SRM experiments. 
During the acquisition, the laser is operated in rastering mode and passes through each MALDI spot 
consuming only a small percentage of the total spot surface per run. This feature offers a convenient re-
analysis capability and flexibility, which allows defining and optimizing the SRM transitions after the 
LC fractionation and MALDI deposition steps. Alternatively direct quantification of low molecular 
weight compounds using high resolution MALDI-TOF 
27
 has been described and recently extended to 
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peptides quantification including an immunocapture step of the peptides in order to maintain the 
selectivity 
28
. 
In the present work, we have investigated the potential of the LC-MALDI-SRM/MS platform to 
analyze complex biological samples. The specific optimization of the analytical platform is discussed 
and illustrated by monitoring a set of proteins from the TCA and glyoxylate cycles, and of the glycolysis 
and gluconeogenesis pathways in Saccharomyces cerevisiae. 
 
Experimental section 
Yeast culture and proteins extraction 
 
The time course of S. cerevisiae cells strain SC288 (ATCC 26108) was performed on 400 ml of liquid 
YPD broth (Sigma Aldrich) in a 1L Erlenmeyer flask at 28°C. The agitation was performed using a 
magnetic stirrer. The culture was inoculated with 5 mL of a 24 H pre-culture (OD=8) grown in liquid 
YPD medium from a single colony harvested on a Sabouraud agar dish. The commercial YPD broth 
consist in bacteriological peptone 20 g/l, yeast extract 10 g/l, glucose 20 g/l.  The cells concentration in 
growth medium was measured with a hemocytometer throughout the time course as well as the optical 
density (OD) at 600 nm. Cells were harvested at 10 time points: 9, 10.5, 12, 20, 23, 25, 27.5, 30, 47 and 
49.5 hours. At each time point, a volume of the culture was immediately cooled in ice-cold water and 
then pelleted by centrifugation (1000xg, 5 min, 2°C). Pellets were washed with an ice-cold buffer 
(HEPES 20 mM, EDTA 2mM, pH 7.5), subsequently frozen in liquid nitrogen and stored at -80°C. The 
glucose concentration in growth medium was determined by a hexokinase enzyme assay (Aldrich) on 
the supernatants resulting from the harvest. 
The pellets were solubilized in a lysis buffer (HEPES 50 mM, glycerol 5%, dithiothreitol 15 mM, KCl 
100 mM, EDTA 5mM, pH 7.5 and a complete protease inhibitor cocktail (Roche), one tablet for 25 ml 
of lysis buffer). Cells numeration using a hemocytometer was performed in triplicate on the aliquots of 
the solubilized pellets.  This numeration was used to rationalize the proteins expression profiles 
expressed in proteins/cell. Cells disruption was performed using 500 µm acid-washed glass beads. 
Proteins concentration of each extract was determined using a BCA assay (Pierce). Proteins extracts 
were precipitated with 8 volumes of cold acetone overnight at -20°C and stored at -80°C until further 
use.  
Tryptic digestion and peptides sulfonation 
 
The proteins pellets were solubilized in 320 µl of 8M urea and 0.1M ammonium bicarbonate buffer, 
reduced with 20 µL of 0.5M dithiothreitol at 30°C for 45 minutes and then alkylated with 60 µl of 0.5 M 
iodoacetamide for 1 hr at room temperature. Aliquots of 300 µg of proteins from the subsequent 
solutions were diluted with 0.1M ammonium bicarbonate in order to reduce urea concentration below 
0.5M (final volume 1470 µl). The isotopically labeled peptides standard mixture (C terminal arginine, 
13
C6, 
15
N4, ∆m=10 u, JPT Peptides Technologies), used for precise quantification, was spiked in each 
sample (30 µl, 50 pmol) before trypsin addition (trypsin/total proteins ratio of 1/75; w/w, total protein 
amount of 300 µg). 
Digestion was performed overnight at 34°C under agitation; the trypsin activity was quenched by neat 
formic acid addition (ca. 20 µl). Samples were desalted onto C18 solid phase extraction cartridges and 
subsequently evaporated to dryness in a vacuum centrifuge. The digest pellets were solubilized with a 
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small amount of MeCN/TFA 0.1% (20/80; v/v) vortex-mixed and sonicated before being diluted with 
aqueous 0.1% TFA solution, aliquoted and stored at -80°C until further analysis. 
Peptides from each time point were derivatized in triplicate by the following procedure. An equivalent 
of 50 µg of the digested sample was evaporated to dryness and subsequently solubilized with 50 µL of 
sulfonation reagent (sodium bicarbonate 20 mM, 4-sulfophenylisothiocyanate 20µg/µl, pH 10). The 
sulfonation reaction was performed at 55°C for 45 min. under agitation. The 4-
sulfophenylisothiocyanate and other reaction by-products were removed by steric exclusion (cut-off of 
700 Da) using a homemade “SpinTrap”-like device packed with Sephadex G10. Elution and 
equilibration steps were done with a 20/80 (v/v) ethanol/water solution. The filtrate was evaporated to 
dryness, solubilized in 10 µl of 1% aqueous TFA solution and further diluted (7 fold) in 0.1% TFA to 
obtain a final pH below 2. 
 
 
Microscale LC-MALDI 
 
The microscale LC-MALDI fraction collection  consists in a column-switching setup with a trapping 
column (1 mm i.d. × 5 mm, 2.7 µm Halo C18 fused-core, Optimize Technologies) and an analytical 
column (1 mm i.d. × 150 mm) packed with the same stationary phase. The loading mobile phase 
consists of 0.1% aqueous TFA delivered at a flow rate of 200 µl/min. A low-pressure binary linear 
gradient from 5 to 60 % B in 15 minutes was delivered through the analytical column by an UHPLC 
pump (Rheos Allegro, Flux Instruments). The eluent A consists of water/MeCN/formic acid (95/5/0.1; 
v/v/v) and eluent B in MeCN/water/formic acid (95/5/0.1; v/v/v), the total analytical flow was set to 50 
µl/min. Samples (35 µg/injection) were loaded for 1 min. onto the trapping column before being eluted 
onto the analytical column. 
A solution of α-cyano-4-hydroxycinnamic acid (CHCA; 20 µg/µl in 90/10 MeCN/0.1% aqueous TFA) 
was infused at 10 µl/min and mixed to the mobile phase flow stream in the MALDI spotter (PAL-HTS 
autosampler equipped with MALDI Spotter option, CTC Analytics). Fraction collection was carried out 
onto hydrophobically coated MALDI plates (µFocus-1700µm, Hudson Surface Technology) at a rate of 
4s/spot. After drying, the MALDI spots were recrystallized by adding 1 µl of MeCN/0.1 %TFA (70/30; 
v/v) in order to improve crystals adhesion to the MALDI plate.  
 
Evaluation of the quantification performances 
 
Yeast’s phosphoglycerate kinase (PGK) was purchased from Sigma Aldrich. Dilutions and sample 
preparation were performed in order to generate the following amounts: 25 ng, 50 ng, 100 ng and 1000 
ng in terms of intact protein equivalent injected onto the column. The four phosphoglycerate kinase 
samples were spiked with a constant amount of peptides internal standard (C terminal arginine, 
13
C6, 
15
N4, ∆m=10 u, JPT Peptides Technologies) and digested in triplicate by trypsin. The PGK digests were 
spiked into human “equalized” plasma that was previously digested by trypsin. The “equalized human 
plasma” was obtained by a partial proteins precipitation with MeCN before the digestion procedure in 
order to “equalize” the proteins concentrations range. In addition, the total proteins concentration was 
determined using a BCA assay (Pierce) in order to generate a well-characterized amount of matrix 
background. In our case 13,4 µg of digested plasmatic proteins were injected onto column along with 
the phosphoglycerate kinase. The peptides sequences of the yeast protein were blasted (NCBI Blastp 
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algorithm) against the human proteome to confirm their uniqueness. For the comparison of the 
quantification performances between the LC-ESI-SRM and the LC-MALDI-SRM platforms the same 
LC setup (LC system, column) was used. For the LC-MALDI experiments, samples were derivatized by 
SPITC, purified by steric exclusion and finally injected onto the chromatographic system. For the LC-
ESI experiments, samples were kept native and the analysis was performed on a 4000 QTRAP equipped 
with a TurboIon electrospray source. The SRM transitions of the native peptides were selected from 
SRMAtlas (http://www.srmatlas.org/). The same amount of sample was injected on both platforms. 
 
MALDI SRM/MS analyses and data processing 
 
MALDI-SRM/MS analyses were performed on a 4000 QTRAP mass spectrometer (QqQLIT) equipped 
with a prototype MALDI source (AB Sciex). The Nd:YAG laser (355 nm) can reach the frequency of 
1000 Hz in order to produce a quasi-continuous ions beam. The 4000 QTRAP mass spectrometer was 
operated in SRM mode with the Q1 and Q3 analyzers set at unit mass resolution. The SRM transitions 
of the selected peptides were acquired with a dwell time of 10 ms. In each case, transitions 
corresponding to the endogenous peptides and the internal standards were measured. During the 
acquisition the laser passes through each spot in rastering mode, and for each MALDI plate column a 
specific SRM transitions set, dedicated to peptides known to be collected along the column, was 
monitored. Three SRM transitions were monitored for each surrogate peptide. The SRM traces 
integration was manually done with MultiQuant software (v. 2.1, AB Sciex) using the summation 
algorithm, the ratio between the light and heavy transitions was calculated. The limit of detection was 
set to a S/N of 3, where the same number of preceding adjacent spots, typically 1-4, was taken for 
calculating the noise as for determining the analyte summed areas. The internal standard interference 
(cross-talk) was assessed by injecting the heavy peptides alone and by monitoring the SRM transitions 
corresponding to the light and heavy peptide pairs and not found to be critical in the present study.  As 
the for low molecular weight compounds and this study is a proof of concept, only the most sensitive 
SRM transition was taken, the others being used as confirmatory transitions. In addition, targeted 
peptide identities were confirmed by a full scan MS/MS spectrum in linear ion trap mode on a 
representative LC-MALDI run of the yeast digest. For the quantification of the proteins, only the peptide 
showing the highest concentration result with the absolute quantification was taken into consideration 
when several peptides are available. Precise quantification (equation 1) was calculated using the ratio 
between the light and heavy peptide SRM peak area multiplied by the known amount of heavy peptide 
and corrected by the number of cells extracted per volume of injection. Results were expressed in 
number of molecules per cell. Relative quantification (equation 2) or “fold change” was obtained from 
the ratio between the light and heavy peptide SRM peak normalized to the reference growth time point.  
 
 
 
Equation 1 
 
 
 
Equation 2 
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with k = correction factor based on the number of cells extracted per injection volume. 
 
Results and discussion 
 
Analytical characteristics of the MALDI-SRM/MS platform  
 
Peptides fragmentation on a MALDI-triple quadrupole MS platform 
 
An important analytical challenge of a LC-MALDI-SRM/MS platform for the quantitative analysis of 
peptides was the lack of an efficient and reliable/predictable fragmentation of singly charged native 
peptides, using the low energy collision cell. This limitation is intrinsic to the MS type used in the actual 
analytical platform, which contrasts to the high energy fragmentation of peptides in the commonly used 
MALDI-TOF/TOF instrumentation
29, 30
. However, a peptide derivatization step prior to their separation 
can overcome this limitation, resulting in predictable and reproducible fragmentation pattern of the 
peptides, which is mandatory for SRM experiments. 
The use of SPITC as chemical derivatization agent enhances and simplifies dramatically the 
fragmentation of singly charged peptides and has been described for qualitative analysis
18, 31, 
.  Wang 
and coworkers
 32
 further optimized the prodedure and reported high conversion rate (>90%) for a model 
peptide and a tryptic digest. In the present study using the same derivatization procedure it was observed 
that the conversation rate was peptide dependent and superior to 50 % as illustrated in figure S5 
(supplementary data). In general, for most of peptides investigated the conversion rate was found to be 
analyte dependent and reached a maximum within the first hour. More important than the conversation 
rate is the reproduducibility of the derivatization step for quantitative analysis. Previous work
29
 and the 
present study show that  quantification is not affected by the derivatization step as the labeled peptide is 
added to the sample and undergo the same reaction. Due to the lack of characterized reference the 
absolute response factor could not be determined for the derivatized peptides, but it was measured that 
the derivatization step under MALDI ionization did not result in a significant change of the signal in full 
scan MALDI mass spectra, suggesting that the ionization efficiency remains similar for both forms of 
the peptides. For quantitative analysis of sulfonated peptides further improvements are required: i) the 
determination of the optimal collision energy for a specific precursor ion mass, and ii) the removal of 
the hydrophobic derivatizing reagent excess by steric exclusion prior the LC chromatography. By 
monitoring 261 SRM transitions corresponding to 37 derivatized peptides, a linear regression equation 
between the collision energy and the peptide m/z was obtained: CE (eV) = 17.5 + 0.044 × m/z (r
2
 = 0.92) 
(see figure S2 of supplementary data). This equation was applied throughout the study to optimize the 
fragmentation of SPITC-derivatized peptides. In addition, sample preparation was improved by adding a 
gel filtration step to remove the SPITC excess, which impedes MALDI matrix crystallization and 
contaminates the LC separation. Further discussion and data are available as Supplementary Material. 
 
Matching the MALDI plate speed to the SRM/MS duty cycle 
 
The source of the MALDI-QqQLIT mass spectrometer combines a fast moving target plate (from 0.1 to 
30 mm/s) and a high repetition rate laser (up to 1000 Hz). This particular setup modifies the current 
acquisition concept inherited from ESI-SRM/MS, thus allowing more flexibility during the acquisition. 
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 With SRM detection the maximum number of transitions monitored during a single run depends of i) 
the MS duty cycle (e.g., for the 4000 QTRAP the fastest duty cycle per SRM transition is of 10ms 
corresponding to 5ms for the transition dwell time and a 5 ms pause time between each transition), and 
of ii) the analyte’s availability for the MS detection depending on the hyphenated technique timescale 
(i.e., few seconds for a chromatographic LC peak to several minutes for an infusion experiment). When 
using LC-ESI-SRM/MS, the number of peptides transitions monitored per run is limited by the 
chromatography taking into account that at least 10-15 data points across the peak were required for an 
adequate definition of the elution profile and thus, integration precision. However, it is possible to 
monitor hundreds of SRM transitions during a LC run by using a scheduled SRM acquisition, but this 
implies that the analytes retention times should be determined in a preliminary analysis 
33
.  
Alternatively, peptides MALDI-SRM/MS analysis can be performed until the whole MALDI spot 
surface has been rastered and the sample consumed. Moreover, the integration of the MALDI-SRM/MS 
signal requires less data points because a rectangular pulse shape is generally observed and does not 
need a peak definition algorithm. In addition, the MALDI plate speed can be adapted to match the MS 
duty cycle in order to acquire enough points across the MALDI spots. As an example Figure 1 shows 
that the acquisition time needed for monitoring a single peptide (i.e., 6 SRM transitions for the 
heavy/light peptides pair) can be as short as 425 ms per spot. When increasing the number of SRM 
transitions to be monitored (e.g., up to 72 transitions), lowering the plate speed (i.e., from 4 to 0.25 
mm/s) will balance the increased MS duty cycle in order to keep the MALDI spots sampling rate 
adequate.  
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Figure 1:  SRM traces of the light and heavy y7 fragment ions of the sulfonated peptide EALDFFAR. 
The SRM traces are extracted from a 72 (left) or 6 (right) SRM transitions set acquired with a 
MALDI plate speed of 0.25 mm/s and 4 mm/s respectively. 
 
The hydrophobically coated MALDI plates with the largest spots diameter of 1.7 mm were selected to 
concentrate droplets of maximal volume; however, droplets larger than 4 µl started to spill over the spot 
edges preventing the hydrophobic coating to concentrate the analytes during the evaporation step. 
Therefore, the matrix and LC flowrates had to be adjusted accordingly, as well as the fraction collection 
rate. With the current microscale LC setup, peptides were eluting over four fractions as shown in Figure 
1. Ideally, a capillary LC setup with a flowrate of 4-5 µl/min and a similar separation power would be 
beneficial for the peptides elution in a single spot, but the use of the summation algorithm for integrating 
the four spots altogether did circumvent this limitation. Further discussion about LC flow-rate and 
sampling frequency is given in the Supplementary Material. 
 
Spatially-mapped MALDI-SRM/MS acquisition strategy 
 
As shown in Figure 1, the area ratios of the light/heavy peptides are not dependent of the plate speed. 
Therefore, it is possible to generate a “spatially-mapped” SRM acquisition (i.e. similar to the LC 
scheduled SRM strategy) with the adaptation of the MALDI plate speed according to the number of 
SRM transitions that have to be monitored in a MALDI spot for an optimal throughput. This approach is 
similar to the LC peak parking technique used with LC-ESI-MS 
34
, but with the advantage of the sample 
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re-analysis capability inherent to the MALDI process. Indeed, one could devise a data-dependent 
acquisition experiment monitoring the peptidic spots content during the MALDI plate rastering. The 
survey scan would trigger SRM experiments and the plate speed would be adapted according to the 
number of SRM transitions to monitor in order to get enough data points across each spot. Compared to 
LC-ESI-SRM/MS the chromatographic separation is “time-frozen” onto the MALDI plate during the 
fraction collection step and navigation throughout the LC run becomes possible without time constraint 
to devise SRM transitions “on-the-fly”. After a rapid SRM screen to determine on which spots the 
peptides of interest are located on the MALDI plate, optimized SRM methods are created and dedicated 
to the peptides present in each spot.  
 
Workflow to select the SRM transitions  
 
Selection of the SRM transitions for peptide analysis with an ESI-SRM/MS platform 
Typical LC-ESI-SRM/MS-based proteomic assays monitor surrogate peptides (so-called signature 
peptides) for protein quantification. For each signature peptide this requires certain knowledge of the 
precursor ion charge state, its fragment ions m/z, as well as the selectivity and sensitivity of the chosen 
SRM transitions. The growth of validated SRM assays databases (e.g., SRMAtlas 
35
) will probably 
simplifies this time-intensive process. When the targeted peptides are not present in those databases, the 
adequate strategy for building an SRM-based assay depends on the actual number of proteins to monitor. 
For a small set of proteins (i.e., 10-20 proteins), the selection of the adequate signature peptides and the 
CID fragmentation optimization can be performed directly on the digest of purified proteins. However, 
the commercial availability of such protein standards is not guaranteed and this approach can be 
expensive for a large-scale proteomics screening. Therefore for larger sets of proteins, an alternative 
strategy consists of extracting the peptides sequences and information about their presence in digested 
biological samples from databases of peptides experimentally observed by mass spectrometry (e.g., 
PeptideAtlas 
36
) or from in-house unsupervised MS(/MS) experiments 
37
. Then the SRM transitions can 
be easily predicted by an in silico fragmentation software and further optimized with synthetic peptides 
11
 or directly extracted from full scan MS/MS spectra. However, these approaches require that a 
preliminary screening of the biological samples should be undertaken with an initial SRM transitions set 
in order to confirm the targeted peptides presence and, if necessary, to further optimize the SRM 
transitions. As a matter of fact, all these strategies to design the optimal SRM transitions set are time-
consuming mainly because of the inherent speed and serial practice of liquid chromatography itself. 
Furthermore the maximum number of SRM transitions monitored per run remains limited and requires 
reliable information about peptides elution times to apply scheduled SRM approaches.  
 
Selection of the SRM transitions for sulfonated peptides with a MALDI-SRM/MS platform  
The flexibility gained by the re-analysis capability of the MALDI technique is of upmost importance 
for the development of quantitative MALDI-SRM-based proteomic assays. For small proteins sets 
MALDI can easily analyze the digest of a single protein without the need of an LC fractionation. The 
complete method optimization, i.e., from the surrogate peptides selection to their CID fragmentation 
optimization and SRM transitions design can be quickly performed with a single MALDI spot (Figure 
2a). 
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Figure 2:  Workflows for the SRM transitions set design when analyzing a) a small set of proteins or b) 
a large set of proteins. 
 
 
The second workflow to design large-scale SRM experiments using the LC-MALDI-SRM/MS 
platform is described in Figure 2b. Since the liquid chromatography separation and the MS detection are 
decoupled, the SRM transitions sets can be directly optimized on a single representative biological 
sample after LC-MALDI fraction collection in order to preserve the study samples. Despite the fact that 
SRM assays databases for SPITC-derivatized peptides are not currently available, the information about 
peptides detectability in similar biological samples can be extracted from databases such as 
PeptideAtlas. Despite of the fact that PeptidesAtlas is composed mainly of ESI-MS data, in many cases 
(provided the constraint of having arginine as C-terminal amino acid residue), the peptides selected in 
this  MALDI-SRM/MS study were top ranked in the database. This is due to a significant overlap 
between MALDI and ESI for peptides ionization 
38
. In addition, the design of the in silico SRM 
transitions set is simplified because with MALDI the precursor charge is always +1 and the systematic 
calculation of the fragments m/z is restricted to the y-ions series due to the SPITC derivatization. This 
strategy produced firstly a broad SRM transitions set used to locate the peptides onto the MALDI plate. 
That step did not necessitate a high number of data points per spot because the idea is to map the 
peptides location of the fractionated LC-MALDI run. Afterwards, the fine-tuning of the best SRM 
transitions for each peptide is performed by re-analysis of the spots containing only the relevant 
information. 
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Comparison of relative and absolute quantification accuracy between ESI- and 
MALDI-SRM/MS methods 
 
In a previous work we investigated the MALDI-SRM/MS capabilities for the absolute quantification 
of a therapeutic mAb using a procedure based on analyte/IS area ratio  calibration  curve.
29
 We found 
that the SPITC derivatization procedure does not systematically improve the limit of quantification but 
dramatically improve the fragmentation and provides additional SRM transitions to increase the 
selectivity of the measurements. Comparison between MS/MS spectra of SPITC derivatized and their 
native forms is available in the figure S1 of the supplementary data. The external calibration offers the 
advantages of an easier adjustment of the actual protein or peptide concentration to the MS response. 
However, its implementation for the quantification of large sets of proteins remains challenging and 
requires a representative biological matrix without endogenous compounds that might interfere with the 
proteins quantification. For instance, the quantification accuracy was assessed by spiking the yeast 
phosphoglycerate kinase (PGK) into an “equalized” human plasma digest, followed by the analysis on 
both the LC-MALDI-SRM/MS and the LC-ESI-SRM/MS platforms. The equalized human plasma 
generates a realistic biological matrix background free from most interference coming from shared yeast 
peptides sequences. With the ESI mode, the peptides were not derivatized with SPITC and the SRM 
transitions were directly extracted from the SRMAtlas database. 
Two signature peptides were selected for the quantification of PGK, and at first glance the ESI and 
MALDI yielded very similar results in terms of accuracy; there is no bias assigned to MALDI (Table 1). 
The relative quantification, or so-called fold-change analysis, is based on the normalization of the 
light/heavy peptides area ratios in comparison to a fixed concentration or state point. The absolute 
quantification obtained via isotopic dilution 
39
 was based on the light/heavy peptides signal ratio 
multiplied by the perfectly known amount of heavy peptides actually spiked in the sample. The results of 
the relative quantification showed acceptable fold change accuracy (i.e. 100% +/- 20%, except for the 
peptide YHIEEEGSR at a concentration ratio of 40 in LC-ESI-SRM/MS) and precision data (i.e., CV 
below 20%). Overall, the observed fold change results ranging from 0.5 to 40 were in accordance with 
the values already observed for similar proteins in yeast 
11, 40
. 
The results of absolute quantification using isotopic dilution of labeled peptides showed a similar 
negative bias of 50 % independently of the peptide and ionization source, the protein concentration is 
actually under evaluated. This bias is probably due to the fact that synthetic peptides do not balance the 
digestion efficiency or issues related to solubilization and stability.  
 
 
 
Table 1: Relative and absolute quantification of the phosphoglycerate kinase signature peptides 
LSELIGAR and YHIEEEGSR by LC-MALDI- or LC-ESI-SRM/MS. For the relative quantification, the 
concentrations ratio of 1 was used as 100%. Accuracy (%) = 100 × (calculated concentration / actual 
concentration).  
 LSELIGAR 
 LC-MALDI  LC-ESI 
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concentrations 
ratio 
accuracy RSD   concentrations 
ratio 
accuracy RSD  
1.00 100% 5%  1.00 100% 6% 
2.00 91% 3%  2.00 91% 16% 
4.00 105% 15%  4.00 107% 15% 
40.00 84% 6%  40.00 85% 9% 
       
concentrations 
ratio 
accuracy RSD   concentrations 
ratio 
accuracy RSD  
0.50 110% 5%  0.50 110% 6% 
1.00 100% 3%  1.00 100% 16% 
2.00 116% 15%  2.00 117% 15% 
20.00 93% 6%  20.00 93% 9% 
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o
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e 
d
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u
ti
o
n
 q
u
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n
ti
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ti
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n
 
theorectical 
injection 
(femtomoles) 
accuracy RSD   theorectical 
injection 
(femtomoles) 
accuracy RSD  
560 46% 5%  560 44% 6% 
1121 42% 3%  1121 40% 16% 
2242 48% 15%  2242 47% 15% 
22418 39% 6%  22418 37% 9% 
        
 YHIEEEGSR 
 LC-MALDI    LC-ESI   
       
re
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e 
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concentrations 
ratio 
accuracy RSD  concentrations 
ratio 
accuracy RSD 
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1.00 100% 11%  1.00 100% 13% 
2.00 91% 1%  2.00 85% 11% 
4.00 95% 11%  4.00 93% 10% 
40.00 83% 7%  40.00 69% 3% 
       
concentrations 
ratio 
accuracy RSD  concentrations 
ratio 
accuracy RSD 
0.50 110% 11%  0.50 118% 13% 
1.00 100% 1%  1.00 100% 11% 
2.00 104% 11%  2.00 110% 10% 
 20.00 91% 7%  20.00 81% 3% 
        
       
is
o
to
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e 
d
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n
 q
u
a
n
ti
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ca
ti
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n
 
theorectical 
injection 
(femtomoles) 
accuracy RSD  theorectical 
injection 
(femtomoles) 
accuracy RSD 
560 49% 11%  560 49% 13% 
1121 45% 1%  1121 42% 11% 
2242 47% 11%  2242 46% 10% 
22418 41% 7%  22418 34% 3% 
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Application to biological samples 
 
As a proof-of-principle the microLC-MALDI-SRM/MS platform was used for the analysis of complex 
biological samples and was applied to a S. cerevisiae growth time course experiment in glucose 
medium. This experiment is similar to the work of Picotti et al. 
11
 in which 45 proteins were monitored 
and quantified from the glycolysis/gluconeogenesis pathway and TCA/glyoxylate cycles by LC-ESI-
SRM/MS. We decided to monitor 17 proteins from these cycles (Table 2) in order to measure the 
enzymes concentration fold changes during the metabolic shift occurring during the transition from 
fermentative to aerobic respiration. In addition, two purity grades of internal standard were used: i) - an 
accurately quantified peptide internal standard used for both the relative and isotopic dilution 
quantifications performed on ten proteins, and ii) - a crude peptide internal standard used for the relative 
quantification of the six remaining proteins.  
 
Relative quantification 
 
The proteins were quantified by taking the time point at 9 hours as the reference, except for ICL1, 
ACH1 IDP2 and MLS1, for which the reference time point was 20 hours (Figure 3). A correction factor 
was applied in order to take into account the number of yeast cells disrupted in each experiment. The 
quantification was performed for one surrogate peptide per protein (shown in bold in Table 2), the 
additional surrogate peptides were used to confirm the expression profiles and were closely matching the 
quantitative profiles. 
 
 
Table 2: Peptides quantified by LC-MALDI-SRM/MS. The peptides in bold were selected for 
absolute or relative quantification, the others were used as confirmatory peptides. 
Gene name [M+H]+ Peptides sequences 
Quantification 
experiment 
devised 
Biological process 
Expression fold 
change after diauxic 
shift 
ALD4 
1432.5 NEGATLITGGER absolute and 
relative 
growth on ethanol 
up-regulated 
1282.5 VAFTGSTATGR 
CIT1 
1522.8 AIGVLPQLIIDR 
absolute and 
relative 
TCA cycle 1970.9 GLVWEGSVLDPEEGIR 
1382.7 VVPGYGHAVLR 
ENO1 
1627.9 LGANAILGVSLAASR absolute and 
relative 
glycolysis / gluconeogenesis 
1022.7 TFAEALR 
FUM1 1224.5 YWGAQTQR 
absolute and 
relative 
TCA cycle 
GLK1 
1618.8 GVLLAADLGGTNFR 
relative glycolysis 
1635.8 HALALSPLGAEGER 
ICL1 1685.8 LFHEAVIDEIER relative glyoxylate cycle 
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KGD1 1417.6 FLQLANEDPR relative TCA cycle 
MDH1 
1548.7 DDLFAINASIVR 
relative TCA cycle 
1879.8 FISEVENTDPTQER 
MLS1 1152.5 YFLPEIR relative glyoxylate cycle 
IDP2 1642.7 ATDVIVPEEGELR relative isocitrate metabolism 
ACH1 1588.7 SQVVSNNPEMIR relative growth on ethanol 
PGK1 
1265.7 YVLEHHPR absolute and 
relative 
glycolysis / gluconeogenesis 
stationary-regulated 
1334.6 YHIEEEGSR 
ENO2 
1629.8 LGANAILGVSMAAAR absolute and 
relative 
glycolysis / gluconeogenesis 
2070.0 TAGIQIVADDLTVTNPAR 
PGI1 
1143.6 AVYHVALR absolute and 
relative 
glycolysis / gluconeogenesis 
1109.5 EFSEQVR 
HXK2 
1073.4 LSELIGAR absolute and 
relative 
glycolysis 
1575.5 TGHIAADGSVYNR 
PYK1 
1037.6 FSHLYR absolute and 
relative 
glycolysis 
1442.7 TNNPETLVALR 
PDC1 1590.6 NPVILADACCSR 
absolute and 
relative 
glucose fermentation 
 
Sample fractionation on the MALDI plate was limited to a 6.4 minutes range from the 15 minutes 
gradient LC run. This provides a coarse but fast fractionation step of the complex biological sample 
compared to LC-ESI-SRM/MS where 30 to 60 minutes chromatographic gradients are of common 
practice for targeted proteomic studies or much longer for unsupervised assays 
41
. The total acquisition 
time with the MALDI triple quadrupole was of 28.8 minutes per sample. However, there is still space 
for optimizing the acquisition time since only 40% of the column length, for a 384 wells MALDI plate, 
is actually dedicated to the sample (the remaining 60% representing the spaces between the spots). But 
the current version of our MALDI source plate controller cannot adapt its speed to go faster in-between 
the spots in order to avoid spending time rastering the region of the MALDI plate without relevant MS 
information.  
Figure 3 shows that the relative proteins quantification profiles are similar to those published by 
Picotti et al. 
11
. Firstly, we observed a group of proteins (ENO2, HXK2, PGI1, PGK1, PYK1 and PDC1) 
with no manifest changes in the  expression level during growth (fold change < 2). These enzymes are 
involves in the glycolysis pathway and alcoholic fermentation (case of the pyruvate decarboxylase 1, 
PDC1). A second group displays an over-expression ranging from 3 to 33 fold after the diauxic shift. 
This change includes the TCA cycle enzymes (CIT1, MDH1, FUM1, KGD1) and it is due to the 
activation of the aerobic respiration metabolism. The aldehyde dehydrogenase 4 (ALD4) is glucose 
repressed and implicated in the oxidation of the ethanol in acetate before its introduction in the TCA 
cycle. ALD4 shows the highest level (33 fold) after 50 hrs of growth. Its induction coincides with the 
end of the glucose consumption. The isoform GLK1 which is de-repressed after the switch to a non-
fermentable carbon source 
42
 is induced by 8 fold. The ENO1 which is repressed by the glucose shows a 
maximum fold change of 6. A third group was formed by the ACH1, implicated in the ethanol 
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conversion to acetyl-CoA via acetate and by ILC1/MLS1, involved in the glyoxylate cycle show an 
induction of 2.5 fold between 20 hrs and 50 hrs of growth. The glyoxylate cycle is implicated in the 
simple carbon source consumption and TCA cycle intermediates regeneration. 
 
 
Figure 3: Time course monitoring of S. cerevisiae proteins involved in carbon metabolism (errors bars 
represent the standard error on the 3 technical replicates) -  . 
A) Yeast growth on glucose medium monitored by the population in the medium, OD at 
600nm and glucose consumption. The OD is also plotted on a neperian logarithmic scale in 
order to evaluate the growth phases. B) Relative quantification of targeted proteins. The fold 
changes are calculated against the 9 hours point (except ICL1, ACH1, MLS1 and IPD2 for 
which the starting point is 20 hours). C) Absolute quantification using isotope dilution. 
Results are expressed in molecules/cell with log2 scale.  
  
Absolute quantification by isotopic dilution 
 
The precise quantification by isotopic dilution of the 19 peptides was based on the amount of spiked 
peptides, which is determined by the supplier. However, the use of synthetic peptides has some well-
known drawbacks. In the case of multimeric proteins, the measured concentrations correspond to the 
protein subunit concentration and not to the active complex. Moreover the quantification via peptides 
standard does not account for the tryptic digestion efficiency. We demonstrated that tryptic peptides 
from the same protein can follow several digestion kinetics 
43
. Therefore, when several surrogate 
peptides are quantified for a protein, only the peptide giving the highest protein concentration will be 
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retained for the protein quantification result. This should minimize the bias from the digestion efficiency 
than can lead to protein quantification under estimation.  
Table 3 compares the results obtained by LC-MALDI-SRM/MS along the time course to affinity-based 
results from the literature 
44
 that are obtained from a single time point. Except for ENO2 and PDC1, the 
results do not deviate from the literature values more than a factor of 3. 
 
 
Table 3: Absolute quantification of peptides using isotopic dilution. Data are expressed as the 
average and the range (i.e., min and max values) along the growth time course.  
a
 Values given from the literature (Ghaemmaghami et al.
44
) 
 
Protein 
Average 
(molecules/cell) 
Min 
(molecules/cell) 
Max 
(molecules/cell) 
Literature values
a
 
(molecules/cell) 
ENO2 1'452'000 1'137'000 2'082'000 3'000 
ENO1 348'000 107'000 715'000 77'000 
CIT1 45'000 3'000 95'000 - 
HXK2 51'000 44'000 56'000 114'000 
PGI1 135'000 110'000 150'000 92'000 
PGK1 431'000 351'000 502'000 314'000 
PYK1 861'000 685'000 1'262'000 291'000 
PDC1 703'000 543'000 902'000 9'000 
FUM1 5'000 3'000 9'000 7'000 
ALD4 32'000 2'000 92'000 22'000 
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Conclusions 
A novel LC-MALDI-MS/MS platform was developed for the quantitative analysis of peptides in 
biological matrices. From an instrumental perspective the system is based on the unique combination of 
a fast rastering MALDI source using a high frequency laser (1000 Hz) for ions generation with a triple 
quadrupole linear ion trap mass spectrometer operated in the selected reaction monitoring mode for high 
sensitivity. The time devoted to the MS acquisition, ranging from 425 ms to several minutes per spot, 
fits the analytical needs of the high throughput analysis of either a few targeted compounds or relatively 
complex proteome studies. As only a small amount of the sample present in one spot (about 8%) is 
consumed during the analysis, thus each spot can be reanalyzed several times under different conditions 
including SRM mode, enhanced product ion mode or MS
3
 mode. The MALDI plates can easily be 
shipped and stored; therefore samples from different laboratories can be analyzed on a single mass 
spectrometer in a high throughput regime. Fragmentation of singly charged peptides was found to be 
peptide sequence dependent and derivatization by sulfonation of the N-terminal α-amino group 
significantly enhanced the fragmentation efficiency under low energy collision induced dissociation. The 
applicability of microscale LC-MALDI-SRM/MS for the quantitative analysis of selected pathways in 
yeast lysate was demonstrated. As the chromatographic step is decoupled from the MS detection and 
still remains the time limiting step, one could envisage parallel LC systems for increasing the throughput 
in combination with orthogonal pre-fractionation techniques, such as strong cation exchange 
chromatography to optimize selectivity. 
The LC-MALDI platform appears to be complementary to the conventional LC-ESI hyphenation for 
SRM based experiments and perfectly suited for the high throughput quantification of small peptides 
sets. Ultimately a specific sample preparation such as immuno-capture and concentration of the targeted 
peptides would allow avoiding the liquid chromatographic fractionation step for an efficient analysis of 
large cohorts of samples as required for biomarkers validation. 
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Supplemental Discussion 
Chemically assisted fragmentation of SPITC-derivatized peptides 
The singly charged peptides, typically produced by MALDI sources, generally display a poor 
fragmentation efficiency under low energy CID 
1
 and post source decay 
2
 on the contrary to their 
multiply charged counterparts generated by electrospray. However, the MS/MS fragmentation efficiency 
of singly charged peptides under low energy CID can be greatly improved by chemically assisted 
fragmentation. In this study, the 4-sulfophenylisothiocyanate was used as derivative agent that reacts 
with the primary amino group at the N-terminus of peptides and generates a mass increase of 215 u. 
Because the SPITC may also react with the amino group of the lysine side chain, arginine-ending 
peptides are preferred; however, lysine-ending peptides can be converted into homoarginine by a fast (5 
min) guanidination reaction 
3
. The sulfonic acid group holds a strong negative charge and a second 
proton is required in order to produce a singly charged peptide. Because the tryptic peptides are ended 
by a basic amino acid residue with a substantial proton affinity, one of the two protons tends to be 
sequestered at the C-terminus of the sulfonated peptide. The second proton is more freely delocalized 
along the peptide backbone and consequently promotes the fragmentation 
4
. Figure S1 illustrates the 
MS/MS fragmentation of both native and SPITC derivatized peptides acquired with the MALDI-QqQLIT 
instrument. Native peptides MS/MS spectra display weak fragmentation efficiency with generally few 
assignable fragments and an overall lower signal to noise. The MS/MS spectra of native peptides are 
more complex than their sulfonated counterparts; they contain a mix of b- and y-ions series, with losses 
of water and ammonia. On the contrary, MS/MS spectra of SPITC derivatized peptides are characterized 
by a clear y-ions series with high signal to noise. However, the b-ion fragments are nearly not detected 
because of the negative charge on the SPITC moiety. Therefore, the fragmentation pattern of sulfonated 
peptides is more suitable for SRM experiments since it efficiently produces predictable fragments ions 
(y-ion fragments). This particular aspect of the chemically assisted fragmentation acts as a selectivity 
enhancer because alternative SRM transitions are available in case of interferences. 
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TFAEALR
TGHIAADGSVYNR
TNNPETLVALR
VAFTGSTATGR
SPITC Native
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AAQDSFAAGWGVMVSHR
AHSSMVGFDLPQR
AIIVLSTSGTTPR
ASAPGSVILLENLR
SPITC Native
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SPITC Native
AVYHVALR
DYIWNTLNSGR
EALDFFAR
EANVTGLR
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 EDDVEEAVQAADR
EFSEQVR
EPVSDWTDDVEAR
 FLGSGPR
SPITC Native
 
 
  
S7 
FSHLYR
GEHINSTEDR
GSIDEQHPR
GLVYETSVLDPDEGIR
SPITC Native
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 IANDIR
 IYEVEGMR
 LGANAILGVSLAASR
LGANAILGVSMAAAR
SPITC Native
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NMFGFESWVGGR
NPVILADACCSR
SISIVGSYVGNR
TAGIQIVADDLTVTNPAR
SPITC Native
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VVPGYGHAVLR
WAGNANELNAAYAADGYAR
YHIEEEGSR
YVLEHHPR
YYGAQTVR
SPITC Native
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 LSELIGAR
LTSLNVVAGSDLR
MSSGYYLGEILR
 NEGATLITGGER
SPITC-peptide Native peptide
 
 
Figure S1: Reconstructed MS/MS spectra of 37 peptides acquired on the MALDI-QqQLIT, both as 
native and SPITC derivatized peptides. Precursor ions were removed by software. 
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Optimization of the collision energy for SPITC-derivatized peptides 
Historically, the N-terminal sulfonation of peptides was designated for post-source decay (PSD) 
experiments on MALDI-TOF instruments. Nowadays, few applications of chemically assisted 
fragmentation were published with MALDI-TOF/TOF (high energy CID) 
5
 or ion trap (low energy 
CID).
6
 There is a lack of data in the literature regarding the optimal collision energy (CE) for 
fragmenting singly charged sulfonated peptides on triple quadrupole or QqTOF instruments. In a 
previous work 
7
 the CE was optimized manually for each transition, this is acceptable for the monitoring 
of few peptides but for the purpose of developing extensive SRM transitions sets, a generic formula 
linking the optimal CE value with the peptides m/z is essential. Therefore, 261 observable SRM 
transitions were selected from 37 derivatized peptides (with precursor ions m/z ranging from 916.5 to 
2212.8 u) and the collision energy was tuned for every SRM transition by steps of 10 eV (Table S1). The 
optimal CE value for each peptide was calculated by averaging the best CE of its SRM transitions. 
These calculated CE values were plotted against the precursor ions m/z (Figure S2). The following linear 
regression equation was obtained: CE (eV) = 17.5 + 0.044 × m/z with a coefficient of determination 
(R2) of 0.92. This formula was used for this present study. 
 
Table S1: Optimized CE for every SRM transitions of 37 peptides sulfonated peptides. The optimal CE 
for a peptide consists in the CE average of the individual SRM transitions. 
peptide Q1 Q3 fragment Optimal CE (eV) averaged CE (eV) 
SISIVGSYVGNR 1466.7 
346.2 y3 75 
78 
445.3 y4 75 
608.3 y5 75 
695.4 y6 85 
752.4 y7 75 
851.4 y8 75 
964.5 y9 85 
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1051.6 y10 85 
1164.6 y11 75 
EALDFFAR 1183.6 
393.2 y3 60 
68 
540.3 y4 80 
655.3 y5 70 
768.4 y6 70 
839.4 y7 60 
NEGATLITGGER 1432.5 
418.2 y4 75 
78 
519.3 y5 75 
632.3 y6 65 
745.4 y7 85 
846.5 y8 75 
974.5 y10 95 
1103.6 y11 75 
VAFTGSTATGR 1282.5 
505.3 y5 75 
70 
592.3 y6 65 
649.3 y7 75 
750.4 y8 65 
897.4 y9 65 
968.5 y10 75 
EDDVEEAVQAADR 1661.5 
560.3 y5 95 
96 
659.4 y6 85 
730.4 y7 115 
859.4 y8 95 
988.5 y9 95 
1087.5 y10 95 
1202.6 y11 105 
1317.6 y12 85 
YYGAQTVR 1172.5 375.2 y3 70 68 
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503.3 y4 70 
574.3 y5 70 
631.5 y6 70 
794.4 y7 60 
FLGSGPR 948.5 
329.2 y3 60 
58 
416.2 y4 60 
473.3 y5 60 
586.3 y6 50 
IANDIR 916.5 
403.2 y3 50 
50 517.3 y4 50 
588.3 y5 50 
VVPGYGHAVLR 1382.7 
387.3 y3 80 
84 
458.3 y4 80 
595.4 y5 90 
652.4 y6 80 
815.5 y7 90 
872.5 y8 90 
969.5 y9 80 
1068.6 y10 80 
DYIWNTLNSGR 1553.6 
319.2 y3 80 
84 
433.2 y4 80 
546.3 y5 90 
647.4 y6 90 
761.4 y7 80 
947.5 y8 80 
1060.6 y9 90 
1223.6 y10 80 
GLVYETSVLDPDEGIR 1977.7 
345.2 y3 120 
103 
474.3 y4 120 
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589.3 y5 120 
686.4 y6 120 
801.4 y7 80 
914.5 y8 90 
1013.5 y9 100 
1100.6 y10 100 
1201.6 y11 90 
1330.7 y12 90 
EANVTGLR 1074.5 
345.2 y3 60 
62 
446.3 y4 60 
545.3 y5 60 
659.4 y6 70 
730.4 y7 60 
GEHINSTEDR 1372.5 
419.2 y3 80 
80 
520.2 y4 80 
607.3 y5 80 
721.3 y6 80 
834.4 y7 80 
971.5 y8 90 
1100.5 y9 70 
NMFGFESWVGGR 1601.6 
388.2 y4 80 
86 
574.3 y5 100 
661.3 y6 90 
790.4 y7 90 
937.5 y8 90 
994.5 y9 90 
1141.5 y10 80 
1272.6 y11 70 
AVYHVALR 1143.6 359.2 y3 70 70 
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458.3 y4 70 
595.4 y5 70 
758.4 y6 70 
857.5 y7 70 
EFSEQVR 1109.5 
402.3 y3 70 
65 
531.3 y4 70 
618.3 y5 60 
765.4 y6 60 
GSIDEQHPR 1253.6 
409.2 y3 75 
81 
537.3 y4 85 
666.3 y5 85 
781.4 y6 85 
981.5 y8 75 
NPVILADACCSR 1590.6 
422.2 y3 70 
83 
582.2 y4 90 
653.3 y5 100 
768.3 y6 80 
839.3 y7 80 
952.4 y8 80 
1065.5 y9 80 
1261.0 y11 80 
WAGNANELNAAYAADGYAR 2212.8 
466.2 y4 120 
106 
581.3 y5 90 
652.3 y6 110 
723.3 y7 110 
886.4 y8 110 
957.4 y9 100 
1028.5 y10 120 
1142.5 y11 110 
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1255.6 y12 120 
1384.7 y13 100 
1498.7 y14 80 
1811.8 y18 100 
IYEVEGMR 1211.6 
363.2 y3 65 
67 
492.2 y4 65 
591.3 y5 75 
720.3 y6 65 
883.4 y7 65 
AIIVLSTSGTTPR 1530.7 
373.2 y3 70 
83 
474.3 y4 80 
531.3 y5 100 
618.3 y6 90 
719.4 y7 80 
806.4 y8 80 
919.5 y9 80 
1018.6 y10 90 
1244.7 y12 80 
EPVSDWTDDVEAR 1733.6 
375.2 y3 90 
96 
474.3 y4 110 
589.3 y5 100 
704.3 y6 80 
805.4 y7 90 
991.5 y8 110 
1106.5 y9 100 
1193.5 y10 90 
1389.6 y12 90 
FSHLYR 1037.6 
338.2 y2 65 
63 
451.3 y3 65 
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588.3 y4 65 
675.4 y5 55 
TNNPETLVALR 1442.7 
359.2 y3 75 
77 
458.3 y4 75 
571.4 y5 75 
672.4 y6 75 
898.5 y8 85 
1126.6 y10 75 
LTSLNVVAGSDLR 1559.7 
403.2 y3 80 
84 
490.3 y4 90 
547.3 y5 80 
618.3 y6 80 
717.4 y7 80 
816.5 y8 90 
930.5 y9 80 
1130.6 y11 100 
1231.7 y12 80 
YVLEHHPR 1265.7 
409.2 y3 75 
78 546.3 y4 85 
887.5 y7 75 
YHIEEEGSR 1334.6 
319.2 y3 90 
83 
448.2 y4 90 
577.3 y5 90 
706.3 y6 80 
819.4 y7 80 
956.4 y8 70 
ASAPGSVILLENLR 1654.8 
402.2 y3 85 
89 531.3 y4 85 
644.4 y5 95 
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757.5 y6 75 
870.5 y7 85 
969.6 y8 95 
1056.6 y9 95 
1113.7 y10 95 
1210.7 y11 95 
1368.8 y13 85 
AHSSMVGFDLPQR 1659.7 
400.2 y3 85 
95 
513.3 y4 105 
628.3 y5 95 
832.4 y7 85 
931.5 y8 95 
1373.7 y12 105 
LSELIGAR 1073.4 
303.2 y3 60 
63 
416.3 y4 60 
529.3 y5 70 
745.4 y7 60 
TGHIAADGSVYNR 1575.5 
452.2 y3 80 
91 
551.3 y4 100 
695.3 y6 100 
810.4 y7 90 
881.4 y8 90 
952.4 y9 90 
1065.5 y10 90 
1259.6 y12 90 
MSSGYYLGEILR 1603.5 
401.3 y3 80 
88 
530.3 y4 90 
587.4 y5 80 
700.4 y6 90 
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863.5 y7 90 
1026.6 y8 90 
1083.6 y9 100 
1257.6 y11 80 
TFAEALR 1022.7 
359.2 y3 65 
63 
488.3 y4 65 
559.3 y5 65 
706.4 y6 55 
LGANAILGVSLAASR 1627.9 
333.2 y3 85 
90 
404.2 y4 85 
517.3 y5 95 
604.3 y6 95 
703.4 y7 75 
760.4 y8 85 
873.5 y9 95 
986.6 y10 95 
1057.6 y11 95 
1171.7 y12 95 
1299.7 y14 95 
AAQDSFAAGWGVMVSHR 2004.8 
399.2 y3 110 
112 
498.3 y4 110 
629.3 y5 110 
728.4 y6 110 
785.4 y7 110 
971.5 y8 120 
1028.5 y9 110 
1099.5 y10 110 
1170.6 y11 100 
1317.7 y12 120 
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1404.7 y13 120 
1519.7 y14 110 
LGANAILGVSMAAAR 1629.8 
317.2 y3 75 
89 
388.2 y4 95 
519.3 y5 105 
606.3 y6 75 
705.4 y7 85 
762.4 y8 85 
875.5 y9 95 
988.6 y10 95 
TAGIQIVADDLTVTNPAR 2070.0 
343.2 y3 100 
103 
457.3 y4 100 
558.3 y5 100 
657.4 y6 100 
758.4 y7 100 
871.5 y8 120 
986.5 y9 120 
1101.6 y10 90 
1172.6 y11 100 
1271.7 y12 100 
1384.7 y13 110 
1512.8 y14 100 
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Figure S2: Plot of the optimal CE in function of the SPITC-derivatized peptide precursor ion m/z. 
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Sample clean up prior LC-MALDI-SRM/MS analysis 
We routinely derivatized 50 µg of a protein tryptic digest with 1 mg of SPITC technical grade reagent.  
It represents a theoretical reagent excess of 100-fold when the average mass of yeast tryptic peptides is 
estimated to 1220 Da 
8
. After the derivatization step, samples contain an excess of SPITC reagent, as 
well as impurities and by-products from the SPITC synthesis (ions with sulfur isotopic patterns) that 
produce severe contamination of the reverse phase chromatography. It is common to perform a sample 
clean up step after SPITC derivatization, usually by using a C18 solid phase extraction (SPE) 
9, 10
.  
However, these contaminants display a significant retention onto the analytical column, and neither 
C18, nor column-switching was suitable to efficiently remove these contaminants from the derivatized 
peptides. The excess of SPITC reagent impedes the crystallization process with CHCA (i.e. bigger 
crystals that do not disintegrate under laser irradiation) and can generate ionization suppression. This 
point was addressed using a size exclusion sample clean up on homemade single use devices packed 
with Sephadex G10 (Figure S3). Fractions 2 and 3 were merged for the analysis. 
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Figure S3: Efficiency of the gel filtration clean-up of a tryptic digest derivatized by SPITC. The first 
four gel filtration eluted fractions were analyzed by: 
- (A) a LC-ESI-QqTOF in negative mode, with a column-switching set up, in order to monitor the main 
contaminants distribution. 
-  (B) a MALDI-SRM/MS in positive mode in order to monitored the peptides distribution in the 
fractions. 
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Sensitivity of the MALDI-SRM/MS platform 
The size of the laser beam on the sample spot is not the real limitation of the MALDI-MS sensitivity. 
Increasing the laser beam size will increase the total number of ions generated but with less efficiency. 
There is a non-linear dependence between laser beam size and ions yield 
11
.  The laser beam area of our 
particular set up is 6.28e-4 cm
2
, it represents 2.8% of a spot surface (1700 µm diameter). During the 
acquisition the laser pass through the MALDI spot linearly (Figure S4 B) in order to increase the 
acquisition time and balance the inhomogeneous distribution of the sample in the spot. The response 
factor is dependent of the density of analytes (molecules/surface) on the sample spot surface until 
analytes suppression effect occurs 
12
. The analytes density on the spot is set by the concentrations in the 
post LC column flow, the volume of the droplet collected onto the MALDI plate and the spot surface. 
According to these considerations the response factor of an LC-MALDI-MS can be enhanced by: 
- a reduction of the spot surface 
- an increased volume of the collected droplets  
- an increased amount of the sample injected onto the LC column 
Smaller spots are not desirable because for a constant MS duty cycle the acquisition speed must be 
reduced in order to keep the data sampling constant. The sampling rate of the LC flow onto the MALDI 
plate is also a critical point; ideally it must be long enough to pool a whole chromatographic peak but in 
the other hand short enough to keep the LC fractionation effective. The LC-MALDI fractionation of 
peptides is usually performed with a nanoscale LC set up, but here a micro-LC configuration was 
selected because of the higher loading capacity of the 1 mm ID analytical column compared to 75 µm ID 
nanoscale columns. However, LC columns with higher ID require higher flow rate (typically 50 µl/min) 
that can lead to a detrimental chromatographic peak splitting over the spots. This issue was adressed by 
using hydrophobic MALDI plates allowing a collection volume of 4 µl/spot at a sampling rate of 4s/spot 
(Figure S4 A). The hydrophobic MALDI plates also offer the advantage of keep the spot surface 
constant during evaporation despite a higher droplet volume. The post-column MALDI matrix infusion 
was performed with a highly concentrated solution at a low flow rate (10 µl/min) in order to limit the 
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dilution of the chromatographic flow. Using these parameters, the chromatographic peaks were split 
over 3 to 5 MALDI spots (see Figure 1 of the manuscript). 
A B
 
 
Figure S4 : A) Picture of an LC-MALDI deposition onto the hydrophobic plate, up to 4 µL can be 
sampled onto a 1700 µm target. 
B) Picture of a MALDI spot after one acquisition in rastering mode, the groove generated by the laser 
appears between the two arrows.  
 
Derivatization rate and ionization of SPITC derivatized peptides 
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Experimental 
 A solution of alcohol dehydrogenase (ADH1) from S. cerevisiae was prepared at 1 µg/µL in 50mM 
ammonium bicarbonate. An aliquot of the ADH1 solution (20 µL) was reduced, alkylated and digested 
by trypsin. Briefly, an amount of 10 µL of DL-dithiothreitol (50 mM in 50 mM ammonium bicarbonate) 
was added in the tube and incubated for 45 min at 60°C. Then, the reduction of cysteine was done by an 
addition of 10 µL of IAM (100 mM in 50 mM ammonium bicarbonate) and the incubation was 
performed in the dark at room temperature for 30 min. Before proteolysis, the sample was diluted by an 
addition of 60 µL of 50 mM ammonium bicarbonate and a proteomic grade trypsin was added to a final 
trypsin / proteins ratio of 1/40 (w/w). The digestion was performed overnight at 37°C and was stopped 
by the addition of 1 µL of neat formic acid. 
A volume (10µL) of tryptic digest was kept native and another one (10µL) was submitted to 4-
sulfophenylisothiocyanate derivatization. The volume was dried under vacuum, suspended in SPITC 
derivatization buffer (SPTIC 10 µg/µL, sodium bicarbonate 20 mM pH 10) and incubated for 45 min at 
55°C. The derivatization was stopped by an addition of 5 µL of TFA aq. 1%. Both native and SPITC 
derivatized digests were desalted onto a C18 ZipTip, directly eluted in 20µL of CHCA (10 µg/µL, in 
60/40 MeCN/TFA aq. 0.1%) and then spotted on the MALDI plate (1 µL by spot). 
The MS full scans of the spot were acquired using the third quadrupole as a linear ion trap. The 
acquisitions were performed using the rastering mode. 
Results 
The SPITC-derivatized peptides are detected by a shift of 215 u from the m/z of their native forms. We 
cannot conclude about the derivatization yield because the peptides are chemically altered and the 
intensity changes relative to a peptide and its derivatized form do not necessarily correlate with their 
actual concentration changes. However, the SPITC derivatization preserves the overall signal to noise of 
the MS spectra and in most case the peaks of the native peptides were found to be 50-80% less intense 
in SPITC derivatized samples. 
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Figure S5 MALDI-QqQLIT MS full scan spectra of ADH1 tryptic digest under its native form and after 
SPITC derivatization. Q3 was operated as a LIT. 
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